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Abstract
Ginkgo biloba L. (Ginkgoaceae) is one of the oldest trees on earth. The medicinal use of its seeds and leaves has been a tra-
dition for thousands of years. The standardized extract (known as EGb 761) contains several biologically active components, 
among them are terpenes and flavonoid glycosides that are responsible for the pharmacological activities of Ginkgonis folium. 
According to European Union herbal monographs (EUHM), the leaves of Ginkgo are recommended for the treatment of 
dementia, cerebral vascular insufficiency, and disorders of the peripheral circulation. The aim of our work was to analyze 
volatile constituents of Ginkgo leaf. Leaves of 3 Ginkgo trees were analyzed; 2 of which grow in the Medicinal Plants Garden 
(young trees A and B) and 1 at the Botanical Garden (old tree C) in Bratislava. The leaves were collected in 2014. The es-
sential oil was isolated and quantified using hydrodistillation according to European Pharmacopoeia (Ph. Eur.) The volatile 
constituents of Ginkgonis folium were evaluated qualitatively and quantitatively using gas chromatography-mass spectrome-
try (GC-MS) and gas chromatography with flame ionization detection (GC-FID). We identified 16 constituents of the leaves 
of tree A, 18 in tree B, and 14 in tree C. The volatiles of the 3 trees differ in the respective amounts of monoterpenoids, 
hydrocarbons, fatty acids, and their methyl esters. The following constituents were identified in all of the 3 trees in largest 
percentage: hexahydrofarnesyl acetone (23.6%, 16.0%, and 27.7%), α-linolenic acid methyl ester (14.8%, 20.7%, and 15.1%), 
and pentacosane (22.2%, 22.4%, and 21.9%). Other identified compounds include the monoterpenes (E)-α-ionone and 
(E)-β-ionone.
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Ginkgo biloba L. (Ginkgoaceae) is a unique plant. The 
Ginkgo tree was able to survive millions of years as the only 
member of a whole class of plants and its leaf extracts are 
commonly used as phytomedicines.1 Herbal medicinal prod-
ucts (EGb 761) were used for the improvement of (age-asso-
ciated) cognitive impairment and of quality of life in mild 
dementia. Traditional herbal medicinal products (Ginkgonis 
folium) were used for the relief of heaviness of legs and the 
sensation of cold hands and feet associated with minor circu-
latory disorders, after serious conditions have been excluded 
by a medical doctor.2-5 Terpenes, flavonoids, organic acids, 
polyacetate derived compounds, hydrocarbons, and miscel-
laneous organic and inorganic compounds were found in 
Ginkgo leaf. Most of the isolated compounds are found ubiq-
uitously in the leaves of higher plants with the exception of 
certain unique terpene trilactones (ginkgolides and bilo-
balide) and flavonoids.6-9
The wood of G. biloba contains small amounts of essen-
tial oil, consisting of mono- (C10), sesquiterpenes (C15), 
and phenylpropanoids.10 Hirao and Shogaki analyzed the 
essential oil of Ginkgo leaves and found polycyclic aromatic 
hydrocarbons such as acenaphthene and 2,5,8-trimethyldi-
hydronaphthalene. Furthermore, monoterpenes (C10) p-cy-
mene and 1,4-dimethyl-2,5-diisopropylbenzene were found. 
Oxygenated compounds were acyclic alcohols as 
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cis-3-hexenol, cis- and trans-4-hexenol, heptade-
ca-3,6,9-trien-1-ol, oxygenated monoterpenes (C10), 2-iso-
propylphenol, thymol, α- and β-ionone, and trans-linalool 
oxide. One phenylpropanoid, p-tolylpropylene, was identi-
fied.11 Irie et al isolated further sesquiterpenes (C15) called 
dihydroatlantones.12 Bilobanone, a sesquiterpene, bears an 
isobutyl substitution on the ring framework.13,14 Zhao et al 
detected 26 constituents in the ether extract of Cretaceous 
Ginkgo coriacea leaves using GC-MS, including 7 fatty 
acids (C8, C9, C10, C12, C14, C16, and C18), 14 n-alkanes 
(C16-C29), 4 phtalates - contaminants, and 2,5-bis(1,1-di-
methylethyl)-phenol. Similarly, 21 constituents were identi-
fied in G. biloba leaves preserved for 150 years and 13 
constituents were found in extant G. biloba. In the preserved 
leaves, the constituents include 5 fatty acids (C14, C15, C16, 
C18, and C18:2), 10 n-alkanes (C14-C21, C26, and C27), 
phtalates - contaminants, and 3 phenolic compounds (3-unde-
cylphenol, 3-tridecylphenol, and 3-pentadecylphenol). In 
extant G. biloba leaves, the constituents include 5 n-alkanes 
(C15-C18, C27), 4 fatty acids (C14, C16, C18, and C18:2), 2 
phtalates - contaminants, and 2 phenolic compounds (3-tri-
decylphenol and 3-pentadecylphenol).15
The aim of our work was to analyze volatile constituents 
of Ginkgo leaf with focus on seasonal/vegetation variability 
and the influence of plant gender of 3 Ginkgo trees were ana-
lyzed; 2 of which grow in the Medicinal Plants Garden 
(young female and male trees A and B) and 1 at the Botanical 
Garden (old female tree C) in Bratislava. The leaves were 
collected in 2014. Leaves were collected in the course of a 
vegetation period from early May to late November. The vol-
atile oil (yellowish color, woody odor) was isolated and 
quantified using hydrodistillation according to Ph. Eur.16
The content of essential oil in our samples was at most 0.2 
mL/kg (tree A), 0.3 mL/kg (tree B), and 0.7 mL/kg (tree C) 
(midsummer samples). The authors11 reported the content of 
essential oil 0.9 mL/kg in a female tree and 0.8 mL/kg in a 
male tree. The oils were distilled into n-hexane as an absorb-
ing medium and dried over anhydrous sodium sulfate. The 
respective volatile compounds were analyzed by thin layer 
chromatography (TLC) to give violet-purple spots (toluol:di-
ethylether (97:3), detection: vanillin in H2SO4).
17
Ginkgo leaf shows the following diagnostic microscopi-
cal characteristics: the upper epidermis consisting of elon-
gated cells with irregular sinuous walls, the lower epidermal 
cells smaller, with a finely striated cuticle and each cell 
shortly papillose; stomata about 60 µm wide, deeply sunken 
with 6-8 subsidiary cells, are more numerous in the lower 
epidermis; mesophyll with clusters of calcium oxalate of 
various sizes (1-100 µm), sometimes showing prism of cal-
cium oxalate; vascular bundle (in groups, with lignified 
walls); mesophyll cells smaller than palisade cells. 
Schizogenic canals can be observed in the peduncle and in 
the mesophyll of the blade of Ginkgo leaf, possibly contain-
ing volatile secrets, similar to other gymnosperms (Figures 1 
and 2).
The volatile constituents of Ginkgonis folium were quali-
tatively and quantitatively evaluated using GC-MS and 
GC-FID. The essential oil components were identified using 
a library of spectra, Kovats indices, and partly authentic 
samples.18-20 Percentage data were calculated by the area 
normalization method without applying FID response factor 
correction and each oil composition was determined 3 times. 
The relative standard deviation was below 5% for each com-
pound. We have identified 16 constituents of the leaves of 
tree A, 18 in tree B, and 14 in tree C. The compounds identi-
fied in the volatile oils of Ginkgo leaf are listed in Tables 1-3.
We identified alkanes: octadecane (C18), nonadecane 
(C19), eicosane (C20), heneicosane (C21), docosane (C22), 
tricosane (C23), tetracosane (C24), pentacosane (C25), 
Figure 1. Microscopic Features of the Transverse Section of 
Ginkgo Leaf.
Figure 2. Microscopic Features of the Transverse Section of 
Ginkgo Leaf (Schizogenic Canals).
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hexacosane (C26), and heptacosane (C27). Some alkanes, 
such as octadecane (C18), nonadecane (C19), and eicosane 
(C20), were identified only in Ginkgo leaves collected from 
young trees A and B. Zhao et al15 identified in G. biloba 
leaves preserved for 150 years and in the ether extract of 
Cretaceous fossils (Ginkgo coriacea leaves) these n-alkanes: 
tetradecane (C14), nonadecane (C19), eicosane (C20), hene-
icosane (C21), docosane (C22), hexacosane (C26), and hep-
tacosane (C27) using GC-MS. Pentadecane (C15), 
hexadecane (C16), heptadecane (C17), oktadecane (C18), 
and heptacosane (C27) were described in fresh Ginkgo 
leaves. Hirao and Shogaki11 analyzed the essential oil of 
Ginkgo leaves and found polycyclic aromatic hydrocarbons 
such as acenaphthene and 
2,5,8-trimethyldihydronaphthalene.
In all trees (young trees A and B, old tree C), fatty acids 
were identified [palmitic (C16), α-linolenic (C18:3) together 
with its methyl ester]. Free linolenic acid (C18:3) was pres-
ent in tree A only. Palmitic acid (C16) was identified in 
young tree A and in tree C (oldest). Ross9 described the fol-
lowing fatty acids in Ginkgo biloba (leaf, seed): myristic 
(C14), α-hydroxypalmitic (C16), stearic (C18), oleic 
(C18:1), linoleic (C18:2), α-linolenic acid (C18:3), arachi-
donic (C20:4), and behenic (C22). We identified α-linolenic 
acid (C18:3) in addition to his findings in our samples.
Hirao and Shogaki11 identified these monoterpenes (C10): 
p-cymene, 1,4-dimethyl-2,5-diisopropylbenzene, cis-3-hex-
enol, cis- and trans-4-hexenol, heptadec-3,6,9-trien-1-ol, 
2-isopropyl-phenol, thymol, trans-linalool oxide, and α- and 
β-ionone. We identified limonene in Ginkgo leaves collected 
from the oldest tree C, and α- and β-ionone in leaves from 
the youngest tree B. An aldehyde, 2-hexenal (degradation 
product of fatty acids), hexahydrofarnesyl acetone (phy-
tone), and an unknown compound (Mr 192) were found in 
trees A, B, and C.
The major volatile compounds in leaves of the 3 trees A, 
B (young), and C (old female) are hexahydrofarnesyl ace-
tone (23.6%, 16.0%, and 27.7%), α-linolenic acid methyl 
ester (14.8%, 20.7%, and 15.1%), and n-pentacosane (22.2%, 
22.4%, and 21.9%), respectively.
Ginkgonis folium extracts contain several biologically 
active components, among them are terpenes (ginkgolides 
and bilobalide) and flavonoid glycosides that are responsible 
for the pharmacological activities. Leaves were collected in 
the course of a vegetation period from early May to late 
November. The content of terpene lactones (ginkgolides and 
bilobalide) varied during this period, with lower levels in 
spring and autumn, and a maximum in midsummer.6-9 The 
content of flavonoid metabolites in Ginkgo leaf varies typi-
cally during a vegetation period as well, with the highest per-
centage in autumn and in fallen leaves.21-23
We tried to confront our results with hydrometeorology 
data. The major volatile compound is hexahydrofarnesyl 
acetone in August samples, when sunshine duration and air 
temperature were very high. Hexahydrofarnesyl acetone and 
n-pentacosane (C25) reached maximum content in summer 
(trees A and C) or in autumn (tree B). α-Linolenic acid 
methyl ester maximum levels were observed in spring (trees 
A and B) and summer (tree C). The content of n-pentacosane 
(C25) was maximal in fallen-off leafage samples (trees A and 
B).
Hexahydrofarnesyl acetone (phytone) [CAS 502-69-2] 
has a long-lasting fresh jasmine, celery, mild waxy, and fresh 
oily odor. It is often used in jasmine-type compositions as a 
flavor and fragrance agent. It is assumed that this compound 
is perceived as the major odor component of Ginkgo leaf 
volatiles.24
Experimental
Plant Material
Ginkgo biloba L. leaves (Ginkgonis folium) were obtained 
from a 15- and a 14-year-old tree (trees A and B) at the 
Medicinal Plants Garden, and from a 50-year-old female tree 
(tree C) at the Comenius University Botanical Garden 
(Bratislava, Slovakia). Leaves were collected in the course 
of a vegetation period from early May to late November. 
Herbarium samples have been deposited at the Department 
of Pharmacognosy and Botany (Comenius University in 
Bratislava, Slovakia).
Plant Samples Preparation
Volatile oils were isolated (from frozen leaves) by hydrodis-
tillation for 4 hours in a Clevenger apparatus, the oils being 
distilled into n-hexane (CENTRALCHEM, Slovakia) as an 
absorbing medium and dried over anhydrous sodium sulfate 
(CENTRALCHEM, Slovakia). The oils were stored in glass 
bottles at 4°C prior to analysis.
Microscopic Analysis
Optical microscope: LEICA DME, trinocular, planachro-
matic objective lens, zoom objective 20×, tube ½; digital 
camera: LEICA EC 3 Mpix; software: LEICA application 
suite 2.4.0 R1, LAS EZ ver. 1.3.0.
GC-FID Conditions
The composition of volatile oil was analyzed on an AGILENT 
6890/5973N GC/FID (Santa Clara, CA, United States) and 
CTC Combi PAL sampler (CTC Analytics AG, Zwingen, 
Switzerland). The operating conditions were as follows: I. 
GC parameters: (a) capillary column: DB-5MS (Sigma-
Aldrich, Saint Louis, MO, United States), 25 m × 200 µm 
ID, 0.33 µm film thickness, stationary phase: 5% diphe-
nyl-/95% dimethylpolysiloxane fused; (b) the oven tempera-
ture was then programmed at 8°C/min from 60°C to 260°C 
(1 minute isothermal); (c) the injector temperature was 
240°C and the injector vents closed for 10 s after which the 
Czigle et al. 7
split ratio was 1:30; (d) samples: 1.0 µL; (e) high quality 
helium was used as carrier gas (flow rate 1.2 mL/min, 37 
cm/s); II. FID parameters: (a) the temperature was 260°C; 
(b) frequency: 50 Hz; (c) data were evaluated by the use of 
MSD ChemStation D.02.00.275 (Agilent) software; and (d) 
percentage data were calculated by the area normalization 
method without applying FID response factor correction and 
each oil composition was determined 3 times. The relative 
standard deviation was below 5% for each compound.
GC-MS Conditions
The composition of volatile oil was analyzed on an AGILENT 
6890/5973N GC/MS (Santa Clara, CA, United States) and 
CTC Combi PAL sampler (CTC Analytics AG, Zwingen, 
Switzerland). The operating conditions were as follows: I. 
GC parameters: (a) capillary column: SLB-5MS (Sigma-
Aldrich, Saint Louis, MO, United States), 30 m × 250 µm 
ID, 0.25 µm film thickness, stationary phase: 5% diphe-
nyl-/95% dimethylpolysiloxane fused; (b) the oven tempera-
ture was then programmed at 8°C/min from 60°C to 260°C 
(4 minutes isothermal); (c) the injector temperature was 
240°C and the injector vents closed for 10 s after which the 
split ratio was 1:30; (d) sample: 1.0 µL; and (e) high quality 
helium was used as carrier gas (flow rate 1.0 mL/min, 37 
cm/s); II. MS parameters: (a) the instrument was operated at 
70 eV in electron impact (EI+) mode, quadrupole analyzer; 
(b) full-scan analyses were performed in the mass range 
40-500 m/z, 3.15 scan.s-1; (c) data were evaluated by the use 
of MSD ChemStation D.02.00.275 (Agilent) software; (d) 
the identification of the compounds was done by comparing 
the retention times and the recorded spectra with spectra 
from the literature, Kovats indices,18-20 and spectral data in 
our own library based on authentic standards.
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